tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsTools for Trading PlatformsData for Hedge FundsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

AMGN Stock Latest News

Amgen (NASDAQ:AMGN) to Slash More Jobs in Second Round of Layoffs
Market NewsAmgen (NASDAQ:AMGN) to Slash More Jobs in Second Round of Layoffs
3d ago
AMGN
Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
The FlyStreet Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
7d ago
AAP
CBT
Wells Fargo upgrades Amgen to Overweight, lowers target to $265
The FlyWells Fargo upgrades Amgen to Overweight, lowers target to $265
7d ago
AMGN
HZNP
Amgen upgraded to Overweight from Equal Weight at Wells Fargo
The FlyAmgen upgraded to Overweight from Equal Weight at Wells Fargo
7d ago
AMGN
Cantor biopharma/biotech analysts to hold analyst/industry conference call
The FlyCantor biopharma/biotech analysts to hold analyst/industry conference call
11d ago
BMY
AMGN
Cantor biopharma/biotech analysts to hold analyst/industry conference call
The FlyCantor biopharma/biotech analysts to hold analyst/industry conference call
11d ago
BMY
AMGN
AMGEN ANNOUNCES 2023 SECOND QUARTER DIVIDEND
Press ReleasesAMGEN ANNOUNCES 2023 SECOND QUARTER DIVIDEND
13d ago
AMGN
Cantor biopharma/biotech analysts to hold analyst/industry conference call
The FlyCantor biopharma/biotech analysts to hold analyst/industry conference call
14d ago
BMY
AMGN
Amgen to present new Repatha combined data from Phase 3 FOURIER trials
The FlyAmgen to present new Repatha combined data from Phase 3 FOURIER trials
19d ago
AMGN
Horizon Therapeutics reports Q4 EPS $1.21, consensus $1.09
The FlyHorizon Therapeutics reports Q4 EPS $1.21, consensus $1.09
19d ago
AMGN
HZNP
Early notable gainers among liquid option names on February 17th
The FlyEarly notable gainers among liquid option names on February 17th
1M ago
DE
ABC
Amgen price target lowered to $260 from $280 at Truist
The FlyAmgen price target lowered to $260 from $280 at Truist
1M ago
AMGN
Amgen price target lowered to $270 from $300 at Argus
The FlyAmgen price target lowered to $270 from $300 at Argus
1M ago
AMGN
Amgen’s Tezspire approved in U.S. for self-administration in severe asthma
The FlyAmgen’s Tezspire approved in U.S. for self-administration in severe asthma
2M ago
AZN
AMGN
Amgen price target lowered to $267 from $282 at SVB Securities
The FlyAmgen price target lowered to $267 from $282 at SVB Securities
2M ago
AMGN
Amgen price target lowered to $275 from $285 at Wells Fargo
The FlyAmgen price target lowered to $275 from $285 at Wells Fargo
2M ago
AMGN
HZNP
Amgen price target lowered to $258 from $268 at RBC Capital
The FlyAmgen price target lowered to $258 from $268 at RBC Capital
2M ago
AMGN
HZNP
Amgen price target lowered to $253 from $276 at BMO Capital
The FlyAmgen price target lowered to $253 from $276 at BMO Capital
2M ago
AMGN
HZNP
Amgen price target lowered to $289 from $307 at Cowen
The FlyAmgen price target lowered to $289 from $307 at Cowen
2M ago
AMGN
Amgen price target lowered to $220 from $240 at Credit Suisse
The FlyAmgen price target lowered to $220 from $240 at Credit Suisse
2M ago
AMGN
Amgen price target lowered to $230 from $240 at Barclays
The FlyAmgen price target lowered to $230 from $240 at Barclays
2M ago
AMGN
Amgen, Horizon Therapeutics receive second request for additional info from FTC
The FlyAmgen, Horizon Therapeutics receive second request for additional info from FTC
2M ago
AMGN
HZNP
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
Press ReleasesAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
2M ago
AMGN
Amgen sees FY23 CapEx about $925M
The FlyAmgen sees FY23 CapEx about $925M
2M ago
AMGN
Amgen sees FY23 adjusted EPS $17.40-$18.60, consensus $18.33
The FlyAmgen sees FY23 adjusted EPS $17.40-$18.60, consensus $18.33
2M ago
AMGN
Amgen reports Q4 adjusted EPS $4.09, consensus $4.09
The FlyAmgen reports Q4 adjusted EPS $4.09, consensus $4.09
2M ago
AMGN
Amgen options imply 3.2% move in share price post-earnings
The FlyAmgen options imply 3.2% move in share price post-earnings
2M ago
AMGN
Notable companies reporting after market close
The FlyNotable companies reporting after market close
2M ago
AMD
AMGN
AbbVie’s Humira drug faces competition in the U.S., FT reports
The FlyAbbVie’s Humira drug faces competition in the U.S., FT reports
2M ago
ABBV
AMGN